Darren J. Guttenberg

Partner

Orange County
darren.guttenberg@lw.com
+1.714.755.8050

PRACTICES

  • Capital Markets
  • Mergers & Acquisitions
  • Public Company Representation

INDUSTRIES

  • Financial Institutions
  • Healthcare & Life Sciences
  • REITs
  • Retail & Consumer Products
  • Technology

BAR QUALIFICATIONS

  • California

EDUCATION

  • JD, University of Southern California Law School, 2013
  • BA, University of California, Los Angeles, 2007

PROFILE

Darren Guttenberg advises public and private companies on a wide array of corporate matters, including mergers and acquisitions, capital markets transactions, securities laws, and corporate governance.

Darren helps companies navigate complex transactions, achieve regulatory compliance, and manage business-critical shareholder issues, including:

  • Mergers and acquisitions
  • Capital markets transactions
  • Joint ventures
  • Shareholder activism
  • General corporate representation

As a versatile lawyer, Darren regularly advises clients across a range of industries. His ability to grasp the big picture allows him to help clients identify effective business solutions even under volatile market conditions and high-pressure situations.

He draws on his wide range of experiences to quickly learn a client’s business and develop trusted relationships.

EXPERIENCE

Darren's representative transactions include advising:

Mergers & Acquisitions

  • INDUS Realty Trust in its US$868 million acquisition by Centerbridge and GIC
  • Publicly traded homebuilding company in its US$520 million acquisition of a private homebuilder
  • Publicly traded REIT in its US$868 million sale to a private equity firm
  • Publicly traded homebuilder in its acquisition of several private homebuilders
  • Publicly traded biopharmaceutical company in its US$70.5 billion sale to a global biopharmaceutical company
  • Publicly traded consumer electronics company in its US$200 million sale to a private equity firm
  • Private business services company in its US$2.0 billion acquisition of a competitive business services company
  • Publicly traded REIT in its US$16.2 billion sale to another REIT
  • Private medical device company in its sale to another medical device company
  • Publicly traded biopharmaceutical company in its defense of a hostile takeover attempt
  • Publicly traded medical device company in its US$1.7 billion sale to a global healthcare company

Capital Markets

  • Homebuilding company in its US$350 million private offering of senior notes
  • Homebuilding company in its public offering of tangible equity units
  • The underwriters in an IPO of common stock of a medical device company
  • REIT in over US$5.6 billion in public offerings of debt and common stock
  • The underwriters in an IPO of a biopharmaceutical company in its US IPO of American depositary shares
  • Homebuilding company in its US$50 million public offering of common stock
  • Biopharmaceutical company in its US$230 million public offering of convertible notes
  • Homebuilding company in its US$250 million private offering of senior notes